| Year |
Citation |
Score |
| 2020 |
Lee JP, Zhang R, Yan M, Duggineni S, Wakeman DR, Niles WL, Feng Y, Chen J, Hamblin MH, Han EB, Gonzalez R, Fang X, Zhu Y, Wang J, Xu Y, et al. Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration. Proceedings of the National Academy of Sciences of the United States of America. PMID 33219123 DOI: 10.1073/pnas.1911444117 |
0.445 |
|
| 2019 |
Lee JY, Acosta S, Tuazon JP, Xu K, Nguyen H, Lippert T, Liska MG, Semechkin A, Garitaonandia I, Gonzalez R, Kern R, Borlongan CV. Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model. Theranostics. 9: 1029-1046. PMID 30867814 DOI: 10.7150/Thno.29868 |
0.373 |
|
| 2019 |
Gonzalez R, Garitaonandia I, Semechkin A, Kern R. Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1919: 43-57. PMID 30656620 DOI: 10.1007/978-1-4939-9007-8_4 |
0.548 |
|
| 2018 |
Garitaonandia I, Gonzalez R, Sherman G, Semechkin A, Evans A, Kern R. Novel Approach to Stem Cell Therapy in Parkinson's Disease. Stem Cells and Development. PMID 29882481 DOI: 10.1089/Scd.2018.0001 |
0.428 |
|
| 2018 |
Christiansen-Weber T, Noskov A, Cardiff D, Garitaonandia I, Dillberger A, Semechkin A, Gonzalez R, Kern R. Supplementation of Specific Carbohydrates Results in Enhanced Deposition of Chondrogenic-Specific Matrix during Mesenchymal Stem Cell Differentiation. Journal of Tissue Engineering and Regenerative Medicine. PMID 29490116 DOI: 10.1002/Term.2658 |
0.464 |
|
| 2016 |
Gonzalez R, Garitaonandia I, Poustovoitov M, Abramihina T, McEntire C, Culp B, Attwood J, Noskov A, Christiansen-Weber T, Khater M, Mora-Castilla S, To C, Crain A, Sherman G, Semechkin A, et al. Neural Stem Cells Derived From Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinsons Disease. Cell Transplantation. 25: 1945-1966. PMID 27931506 |
0.39 |
|
| 2016 |
Garitaonandia I, Gonzalez R, Christiansen-Weber T, Abramihina T, Poustovoitov M, Noskov A, Sherman G, Semechkin A, Snyder E, Kern R. Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease. Scientific Reports. 6: 34478. PMID 27686862 DOI: 10.1038/Srep34478 |
0.452 |
|
| 2016 |
Gonzalez R, Hamblin MH, Lee JP. Neural Stem Cell Transplantation and CNS Diseases. Cns & Neurological Disorders Drug Targets. PMID 27577573 DOI: 10.2174/1871527315666160815164247 |
0.409 |
|
| 2016 |
Gonzalez R, Garitaonandia I, Poustovoitov M, Abramihina T, McEntire C, Culp B, Attwood J, Noskov A, Christiansen-Weber T, Khater M, Mora-Castilla S, To C, Crain A, Sherman G, Semechkin A, et al. Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease. Cell Transplantation. PMID 27213850 DOI: 10.3727/096368916X691682 |
0.48 |
|
| 2015 |
Eckert A, Huang L, Gonzalez R, Kim HS, Hamblin MH, Lee JP. Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke. Stem Cells Translational Medicine. 4: 841-51. PMID 26025980 DOI: 10.5966/Sctm.2014-0184 |
0.395 |
|
| 2015 |
Gonzalez R, Garitaonandia I, Crain A, Poustovoitov M, Abramihina T, Noskov A, Jiang C, Morey R, Laurent LC, Elsworth JD, Snyder EY, Redmond DE, Semechkin R. Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease. Cell Transplantation. 24: 681-90. PMID 25839189 DOI: 10.3727/096368915X687769 |
0.517 |
|
| 2015 |
Semechkin R, Gonzalez R, Garitaonandia I, Poustovoitov M, Abramihina T, Noskov A, Snyder EY, Redmond DE. Human parthenogenetic derived neural stem cells for the treatment of parkinson’s disease Cytotherapy. 17: S16. DOI: 10.1016/J.Jcyt.2015.03.337 |
0.508 |
|
| 2013 |
Gonzalez R, Garitaonandia I, Abramihina T, Wambua GK, Ostrowska A, Brock M, Noskov A, Boscolo FS, Craw JS, Laurent LC, Snyder EY, Semechkin RA. Deriving dopaminergic neurons for clinical use. A practical approach. Scientific Reports. 3: 1463. PMID 23492920 DOI: 10.1038/Srep01463 |
0.395 |
|
| 2012 |
Parsons JF, Smotrich DB, Gonzalez R, Snyder EY, Moore DA, Parsons XH. Defining Conditions for Sustaining Epiblast Pluripotence Enables Direct Induction of Clinically-Suitable Human Myocardial Grafts from Biologics-Free Human Embryonic Stem Cells. Journal of Clinical & Experimental Cardiology. PMID 22905333 DOI: 10.4172/2155-9880.S9-001 |
0.523 |
|
| 2011 |
Gonzalez R, Lee JW, Schultz PG. Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells. Angewandte Chemie (International Ed. in English). 50: 11181-5. PMID 22191091 DOI: 10.1002/Anie.201103909 |
0.689 |
|
| 2011 |
Lee JW, Hirota T, Peters EC, Garcia M, Gonzalez R, Cho CY, Wu X, Schultz PG, Kay SA. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angewandte Chemie (International Ed. in English). 50: 10608-11. PMID 21954091 DOI: 10.1002/Anie.201103915 |
0.625 |
|
| 2011 |
Gonzalez R, Lee JW, Snyder EY, Schultz PG. Dorsomorphin promotes human embryonic stem cell self-renewal. Angewandte Chemie (International Ed. in English). 50: 3439-41. PMID 21384475 DOI: 10.1002/Anie.201005659 |
0.678 |
|
| 2010 |
Vaziri H, Chapman KB, Guigova A, Teichroeb J, Lacher MD, Sternberg H, Singec I, Briggs L, Wheeler J, Sampathkumar J, Gonzalez R, Larocca D, Murai J, Snyder E, Andrews WH, et al. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming. Regenerative Medicine. 5: 345-63. PMID 20230312 DOI: 10.2217/Rme.10.21 |
0.416 |
|
| 2010 |
Gonzalez R, Jennings LL, Knuth M, Orth AP, Klock HE, Ou W, Feuerhelm J, Hull MV, Koesema E, Wang Y, Zhang J, Wu C, Cho CY, Su AI, Batalov S, et al. Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency. Proceedings of the National Academy of Sciences of the United States of America. 107: 3552-7. PMID 20133595 DOI: 10.1073/Pnas.0914019107 |
0.619 |
|
| 2008 |
Gonzalez R, Loring JF, Snyder EY. Preparation of autogenic human feeder cells for growth of human embryonic stem cells. Current Protocols in Stem Cell Biology. Unit 1C.5.1-1C.5.15. PMID 18770638 DOI: 10.1002/9780470151808.Sc01C05S4 |
0.524 |
|
| 2007 |
Redmond DE, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z, Lipton SA, Markakis EA, Roth RH, Elsworth JD, et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 12175-80. PMID 17586681 DOI: 10.1073/Pnas.0704091104 |
0.435 |
|
| 2007 |
Lee JP, Jeyakumar M, Gonzalez R, Takahashi H, Lee PJ, Baek RC, Clark D, Rose H, Fu G, Clarke J, McKercher S, Meerloo J, Muller FJ, Park KI, Butters TD, et al. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nature Medicine. 13: 439-47. PMID 17351625 DOI: 10.1038/Nm1548 |
0.444 |
|
| 2007 |
Gonzalez R, Loring JF, Wesselschmidt RL, Schwartz PH. Human Embryonic Stem Cell Culture Human Stem Cell Manual. 3-17. DOI: 10.1016/B978-012370465-8/50006-5 |
0.454 |
|
| 2006 |
Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, Liu Y, Shin S, Plaia TW, Auerbach JM, Arking DE, Gonzalez R, Crook J, Davidson B, Schulz TC, Robins A, et al. Human embryonic stem cells have a unique epigenetic signature. Genome Research. 16: 1075-83. PMID 16899657 DOI: 10.1101/Gr.5319906 |
0.5 |
|
| 2006 |
Liu Y, Shin S, Zeng X, Zhan M, Gonzalez R, Mueller FJ, Schwartz CM, Xue H, Li H, Baker SC, Chudin E, Barker DL, McDaniel TK, Oeser S, Loring JF, et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. Bmc Developmental Biology. 6: 20. PMID 16672070 DOI: 10.1186/1471-213X-6-20 |
0.474 |
|
| 2002 |
Sharp SB, Villalvazo M, Huang M, Gonzalez R, Alarcon I, Bahamonde M, D'Agostin DM, Damle S, Espinosa A, Han SJ, Liu J, Navarro P, Salguero H, Son J, Vu S. Further characterization of BC3H1 myogenic cells reveals lack of p53 activity and underexpression of several p53 regulated and extracellular matrix-associated gene products. In Vitro Cellular & Developmental Biology. Animal. 38: 382-93. PMID 12534338 DOI: 10.1290/1071-2690(2002)038<0382:Fcobmc>2.0.Co;2 |
0.404 |
|
| 2002 |
Sharp SB, Villalvazo M, Espinosa A, Damle S, Padilla X, Hartono J, Gonzalez R, Vu S. Bc3h1 myogenic cells produce an infectious ecotropic murine leukemia virus. In Vitro Cellular & Developmental Biology. Animal. 38: 378-81. PMID 12534337 DOI: 10.1290/1071-2690(2002)038<0378:Bmcpai>2.0.Co;2 |
0.386 |
|
| Show low-probability matches. |